# Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers

> **NCT02596360** · PHASE1 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 20 (actual)

## Conditions studied

- Experimental Pain
- Hyperalgesia

## Interventions

- **DRUG:** Pulmodexane® 30mg
- **DRUG:** lactose

## Key facts

- **NCT ID:** NCT02596360
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596360, "Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02596360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*